| 廖红华,段砚方,李厚东.试论活血化瘀药在病理性瘢痕中的应用进展[J].中国烧伤创疡杂志,2020,(3):207~210. |
| DOI： |
| 中文关键词: 活血化瘀 病理性瘢痕 增生性瘢痕 瘢痕疙瘩 应用进展 |
| 英文关键词:Blood-activating and stasis-resolving drugs Pathological scar Hypertrophic scar Keloid Application progress |
| 基金项目: |
|
| 摘要点击次数: 1957 |
| 全文下载次数: 4201 |
| 中文摘要: |
| 病理性瘢痕是皮肤损伤后结缔组织过度增生所致，其形成机制错综复杂，尚未完全明确。中医学认为，通过中医辨证分析，根据患者实际情况，以气滞血瘀、经络阻塞为病机关键，通过中药内服、中药外敷、中药针剂及内外合剂等不同方式治以活血化瘀、清热软坚，在病理性瘢痕的防治中可取得满意的临床疗效。为进一步指导活血化瘀药在病理性瘢痕中的应用，笔者对病理性瘢痕的传统医学认识，活血化瘀药抑制病理性瘢痕形成的作用机制及活血化瘀药在病理性瘢痕中的应用进展进行了综述。 |
| 英文摘要: |
| 【Abstract】 Pathological scars are caused by excessive hyperplasia of connective tissue after skin injury. The mechanism of its formation has not been completely identified due to its complexity. According to Chinese medicine, Qi-stagnancy and blood stasis, and meridian obstruction are the key pathogenesis for its formation, so oral administration of TCM and external application of TCM, injection of TCM, and internal and external mixture of TCM can be used based on patient’s condition to promote their blood circulation, remove stasis and clear away heat. Such treatment can achieve satisfactory clinical effect. To provide guidance for the application of blood-activating and stasis-resolving drugs in the treatment of pathological scar, the author introduced pathological scar, the mechanism of such drugs in inhibiting pathological scar formation, and its application progress in the treatment of pathological scar. |
|
|
|
|
